Squarepoint Ops LLC

Position in ORIC — Oric Pharmaceuticals, Inc.

CIK 1642575 NEW YORK, NY

Position in ORIC

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$3,729,234

+$1,852,882 QoQ

Shares Held

344,343

+50.1% QoQ

Ownership

0.332%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#59

of 179 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 0% Shared 100% None 0%

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $1,234,876,212 across 255 Biotechnology names. ORIC ranks #55 (0.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	198,567	$123,814,467
2	BBIO	BridgeBio Pharma, Inc.	1,191,732	$88,760,199
3	ALNY	Alnylam Pharmaceuticals, Inc.	233,999	$70,440,718
4	INSM	INSMED Inc	616,464	$65,727,391
5	ARGX	Argenx SE	58,400	$54,181,768
6	RYTM	Rhythm Pharmaceuticals, Inc.	422,921	$46,956,918
7	APGE	Apogee Therapeutics, Inc.	290,713	$38,586,336
8	AXSM	Axsome Therapeutics, Inc.	154,605	$37,842,665

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,729,234	344,343	+50.1%	Shares	Defined	2026-08-14
2025-12-31	$1,876,352	229,383	+646.4%	Shares	Defined	2026-02-13
2025-09-30	$368,796	30,733	-71.2%	Shares	Defined	2025-11-14
2025-06-30	$1,083,685	106,767	+540.6%	Shares	Defined	2025-08-27
2024-09-30	$170,826	16,666	-51.0%	Shares	Defined	2024-11-14
2024-06-30	$240,266	33,984	+95.6%	Shares	Defined	2024-08-14
2024-03-31	$238,851	17,371	-33.3%	Shares	Defined	2024-05-15
2023-12-31	$239,715	26,056	-30.3%	Shares	Defined	2024-02-14
2023-03-31	$213,180	37,400	-36.7%	Shares	Defined	2023-05-15
2022-06-30	$264,647	59,073	+328.7%	Shares	Defined	2022-08-15
2022-03-31	$73,585	13,780	+33.2%	Shares	Defined	2022-05-16
2021-03-31	$253,379	10,342	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.